Verrica Pharmaceuticals's total assets for Q1 2026 were $38.79M, a decrease of -17.71% from the previous quarter. VRCA total liabilities were $22.73M for the fiscal quarter, a 1.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.